APA

Rusz O., Kószó R., Dobi Á., Csenki M., Valicsek E., Nikolényi A., Uhercsák G., Cserháti A. & Kahán Z. (2018). Clinical benefit of fulvestrant monotherapy in the multimodal treatment of hormone receptor and HER2 positive advanced breast cancer: a case series. : OncoTargets and therapy.

Chicago

Rusz Orsolya, Kószó Renáta, Dobi Ágnes, Csenki Melinda, Valicsek Erzsébet, Nikolényi Alíz, Uhercsák Gabriella, Cserháti Adrienne and Kahán Zsuzsanna. 2018. Clinical benefit of fulvestrant monotherapy in the multimodal treatment of hormone receptor and HER2 positive advanced breast cancer: a case series. : OncoTargets and therapy.

Harvard

Rusz O., Kószó R., Dobi Á., Csenki M., Valicsek E., Nikolényi A., Uhercsák G., Cserháti A. and Kahán Z. (2018). Clinical benefit of fulvestrant monotherapy in the multimodal treatment of hormone receptor and HER2 positive advanced breast cancer: a case series. : OncoTargets and therapy.

MLA

Rusz Orsolya, Kószó Renáta, Dobi Ágnes, Csenki Melinda, Valicsek Erzsébet, Nikolényi Alíz, Uhercsák Gabriella, Cserháti Adrienne and Kahán Zsuzsanna. Clinical benefit of fulvestrant monotherapy in the multimodal treatment of hormone receptor and HER2 positive advanced breast cancer: a case series. : OncoTargets and therapy. 2018.